Journal of Immunotherapy

Lippincott Williams & Wilkins

Evaluation status available after sign-in

About the journal

Journal of Immunotherapy is a journal published by Lippincott Williams & Wilkins in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Lippincott Williams & Wilkins
ISSN
1524-9557 · 1537-4513
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 1997-01-01
  • PUBMED · 2021-04-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
116 days received→accepted — computed from PubMed (n=88)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3344

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

124

i10-index

1640

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
100%
ORCID iDs in current deposits
31%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9706083
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
Show all subjects (50)
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • vaccines and immunoinformatics approaches
  • vaccines and immunoinformatics approaches
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Immune cells in cancer
  • Immune cells in cancer
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Toxin Mechanisms and Immunotoxins
  • Toxin Mechanisms and Immunotoxins
  • Cytomegalovirus and herpesvirus research
  • Cytomegalovirus and herpesvirus research
  • Cytokine Signaling Pathways and Interactions
  • Cytokine Signaling Pathways and Interactions
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Lung Cancer Treatments and Mutations
  • Chemokine receptors and signaling
  • Lung Cancer Treatments and Mutations
  • Chemokine receptors and signaling
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: